Back to Journals » Therapeutics and Clinical Risk Management » Volume 17
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Italian Real-World Analysis of a Tyrosine Kinase Inhibitor Administration as First- or Second-Line of Therapy in Patients with Chronic Myeloid Leukemia
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
4,233 | Dovepress* | 3,983+ | 506 | 4,489 | |
PubMed Central* | 250 | 93 | 343 | ||
Totals | 4,233 | 599 | 4,832 | ||
*Since 8 June 2021 |
View citations on PubMed Central and Google Scholar